Financial statements are reported in EUR. Prices converted from USD at today's exchange rate. Tranches and alerts stay in USD.
FMS — Fresenius Medical Care AG
€19.98
+€0.39 (+1.99%)
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Market Cap
€10.37B
Forward P/E
9.2x
52-Week Range
N/A
FMS Price History
Revenue vs. Net Income
€19.6B
Revenue · FY2025
Annual. Net margin is shown under each year.
Free Cash Flow
€1.8B
FCF · FY2025
Annual. FCF margin is shown under each year.
Return on Capital Employed (ROCE)
7.7%
ROCE · FY2025
Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.
Total Assets vs. Total Liabilities
1.8x
Assets ÷ liabilities · FY2025
Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.
CapEx as % of Revenue
4.7%
CapEx · FY2025
Annual. Green at or under the 5% maximum target, red above it.
Shares Outstanding
-0.8%
Net buyback · FY2025
Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).
